The Moroccan Industrial and Commercial Property Office granted the company its first Moroccan patent, which contains claims to pharmaceutical formulations effective to deliver a pharmaceutical agent across oral membranes as well as device and method claims.
Rose Perri, COO of Generex, said: “While our regulatory scope in the Middle East region expands, the granting of this application in Morocco is a timely one. We look forward to other patent grants that will augment the value of our increasing intellectual property portfolio.”